Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

Life science laboratories saw a massive drop in demand last year after the NIH was forced to cancel billions of dollars in ...

OpenAI has unveiled GPT‑Rosalind, its first AI model tailored for life sciences, aimed at accelerating research in biology, drug discovery, and translational medicine. Named after DNA pioneer Rosalind ...

Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach ...

Rosalind, to support research into biology, drug discovery and translational medicine. The model is built to improve scientific workflows by helping researchers analyze literature, generate hypotheses ...

OpenAI have announced the early release of its new AI-powered life sciences application GPT-Rosalind to specific life science groups.

OpenAI’s new research says AI and ChatGPT can accelerate life sciences, cut drug R&D delays, and bridge gaps slowing ...

The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, ...

Natasha Nikolaidis, MS, specializes in research operations and shared resource management, project and financial management, business planning, and strategic planning. She enhances research ...

The Spanish government is taking its chance on Boston’s booming life sciences hub, opening an Economic and Trade Commission ...

London, Apr 23 (PTI) A new MoU between the Centre for Cellular and Molecular Platforms (C-CAMP) and Imperial College London has paved the way for deepening India-UK ties in the life sciences sector.

OpenAI has launched GPT-Rosalind, a large language model tailored for life sciences, aiming to aid genomic analysis, experimental design, and drug discovery. The model shows leading performance on a ...